poisar

Stock

Tango Therapeutics, Inc. TNGX

$26.11+5.45%

Overview

TNGX market data

Price History

TNGX price chart · 1M
O
24.67
H
26.83
L
24.38
C
26.11
Vol
148,968.00
Source
US equities market feed
Observed
Aug 26, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$24.67
Previous Close
$24.76
Day High
$26.83
Day Low
$24.38
52 Week High
$34.35
52 Week Low
$16.12
7 Day Return
+3.57%
30 Day Return
-2.36%
90 Day Return
+30.62%
1 Year Return
+54.04%
Daily Notional Volume
$3.9M
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.87
Diluted earnings per share over the trailing twelve months.
Beta
1.17
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-151.2%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$6.25 – $34.39
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $4.3B · P/B 1.67 · P/S 65.17.

Company News

10 captured
HC Wainwright & Co. Maintains Buy on Tango Therapeutics, Raises Price Target to $68Benzinga · Aug 18, 2026, 11:25 AM
Guggenheim Maintains Buy on Tango Therapeutics, Raises Price Target to $35Benzinga · Aug 12, 2026, 12:24 PM
Tango Therapeutics Files Prospectus For Up To $400M Common Stock OfferingBenzinga · Aug 11, 2026, 9:14 PM
8-K filing — Tango Therapeutics, Inc. (TNGX)SEC EDGAR · Aug 11, 2026, 9:13 PM
Tango Therapeutics Q2 EPS $(0.37) Misses $(0.32) EstimateBenzinga · Aug 11, 2026, 11:27 AM
8-K/A filing — Tango Therapeutics, Inc. (TNGX)SEC EDGAR · Aug 7, 2026, 10:41 AM
Reported Earlier, Tango Therapeutics Announces Executive Chairman Dr. Barbara Weber To Step Down From Board Role To Pursue Other VenturesBenzinga · Aug 7, 2026, 8:00 AM
Tango Therapeutics Announces Executive Chair TransitionGlobenewswire Inc · Aug 6, 2026, 11:15 PM
Mizuho Maintains Outperform on Tango Therapeutics, Raises Price Target to $40Benzinga · Jul 17, 2026, 6:59 PM
This Veracyte Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For WednesdayBenzinga · Jul 15, 2026, 10:59 AM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock